Knight Therapeutics Inc.
Knight Therapeutics Inc. (KHTRF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KHTRF · as of Jun 9, 2026
Key Statistics
Explore Knight Therapeutics Inc. Data
khtrf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
khtrf competitorsKHTRF
AGYTF
AVCTF
BOVNF
CLHLF
CRLBFStock Performance
Full HistoryAbout Knight Therapeutics Inc.
Knight Therapeutics Inc. operates as a specialized pharmaceutical enterprise, actively engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of a broad spec…
what is knight therapeutics inc. · khtrf stock overview · knight therapeutics inc. company profile · who is knight therapeutics inc. ceo · khtrf OTC · knight therapeutics inc. headquarters · knight therapeutics inc. business segments
About Stock Overview & Key Data
Knight Therapeutics Inc. (KHTRF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Apr 3, 2014. As of the latest trading session, KHTRF stock price is $6.48, with a market capitalization of $635.3M. The stock has returned +46.94% over the past 12 months and +48.97% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Knight Therapeutics Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Knight Therapeutics Inc. reported revenue of $449.7M and net income of -$5.4M. For detailed data — including Knight Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Knight Therapeutics Inc. (KHTRF) stock price is $6.48. The stock is traded on OTC under the ticker symbol KHTRF. The 52-week range is $4.07 – $6.54.